-
PLoS patching: research reveals the mechanism of herpes virus "on" and "off"
Time of Update: 2019-11-18
November 18, 2019 / Biovalley BIOON / -- recently, a new mechanism has been discovered by Dr Luis M schang and his team from Baker Institute of animal health, which plays an important role in controll
-
Second progressive multiple sclerosis (SPMS) is the first oral drug! Mayzent, a new generation of S1P receptor modulator of Novartis, is about to be approved by EU!
Time of Update: 2019-11-18
November 18, 2019 / BIOON / - Novartis, a Swiss pharmaceutical giant Novartis recently announced that the European Drug Administration (EMA) Committee on human medicinal products (CHMP) has issued a p
-
Scientists dissect the microbial clues of liver diseases
Time of Update: 2019-11-18
November 19, 2019 / BIOON / -- in 1984, microbiologist Barry Marshall studied himself as an experimental object In order to prove that bacteria can cause gastric ulcer, he drank the contents of the fl
-
How do different kinds of vitamins improve human body health?
Time of Update: 2019-11-18
We all know that vitamins are good for your health, so what are the benefits of different kinds of vitamins? In this article, the editor will sort out the relevant research and share it with you! Phot
-
Cell host microbe: new research helps to develop malaria vaccine
Time of Update: 2019-11-18
November 18, 2019 / BIOON / -- recently, Professor Denise Doolan and others of Australian Institute of tropical health and medicine (aithm) published an article, which narrowed the scope of vaccine an
-
Novel small molecules are expected to resist the action of oncogenic KRAS protein
Time of Update: 2019-11-18
November 19, 2019 / BIOON / -- KRAS gene mutation is considered to be the most common driver of tumor occurrence in the whole human cancer spectrum Despite its popularity, the mutated KRAS protein is
-
PLoS patch: how Crohn's disease-related bacteria produce antibiotic tolerance
Time of Update: 2019-11-18
November 18, 2019 / biool / -- according to a recent study published in the journal PLoS patterns, bacteria associated with Crohn's disease rely on a variety of stress responses to survive, reproduce
-
Why can human antibodies deal with various pathogens? Two studies of nature reveal that V (d) J recombination and antibody class conversion recombination are caused by chromatin ring extrusion
Time of Update: 2019-11-17
November 17, 2019 / BIOON / - -- our ability to fight against many potential pathogenic factors we encounter depends on a process called recombination, which can occur in different ways, such as V (d)
-
Nature: does HPV cause cancer? At least part of the HPV silently protects us from cancer
Time of Update: 2019-11-16
November 16, 2019 / Biovalley BIOON / - -- in a new study, researchers from Massachusetts General Hospital, Harvard Medical School and the University of Louisville found that although the virus has be
-
New psoriasis drug! The second phase III study of bimekizumab, a double effect inhibitor of IL-17A / 17F, was successful!
Time of Update: 2019-11-16
November 16, 2019 / BIOON / - UCB, a Belgian pharmaceutical company, recently published the positive results of phase III clinical study be ready to evaluate the efficacy of bimekizumab in the treatme
-
Science: revealing the mechanism of neutrophils inhibiting allergic airway inflammation
Time of Update: 2019-11-16
November 16, 2019 / bioun / - -- allergic airway inflammation, including asthma, is a complex disease A variety of immune and non immune factors promote the occurrence and progress of this disease Mob
-
Nature: reveal how B cells produce new antibodies
Time of Update: 2019-11-16
November 16, 2019 / Biovalley BIOON / - -- in a new study, researchers from Boston Children's Hospital in the United States learned more about the process of V (d) J recombination and how to use chrom
-
Nature: reveal the selective inhibition of Vista protein on T cells
Time of Update: 2019-11-16
November 16, 2019 / bioin / - -- Co inhibitory immune receptor may cause T cell dysfunction in cancer patients The blocking antibodies targeting cytotoxic T lymphocyte associated protein 4 (CTLA-4) an
-
A new anti-inflammatory drug: Novartis cosentix in the treatment of non radiologic axial spondyloarthroarthritis (NR axspa) phase III research success
Time of Update: 2019-11-16
November 16, 2019 / BIOON / -- Novartis, a Swiss pharmaceutical giant Novartis recently announced at the 2019 annual meeting of American rheumatology society / Rheumatology Health Professionals Associ
-
Cell Rep: insulin improves mosquito immune response to West Nile virus
Time of Update: 2019-11-16
November 16, 2019 / BIOON / -- recently, a study led by Washington State University provided a new solution to inhibit the spread of West Nile virus, Zika virus and dengue virus In a study published t
